Search

Gdf -11 a new target to improve anemia in thalassemia.

 

β-thalassemias are characterized by ineffective red blood cell (RBC) production, leading to anemia, iron overload, and organ failure. As current treatment options for β-thalassemia are limited, there is a clear unmet need for alternative therapies.

Read more

Report Drug Shortages to EHA

In an effort to mitigate shortages of hematologic drugs in Europe, EHA is collecting and compiling reports of shortages. Are you experiencing, or foreseeing drug shortages in your clinical practice?

Please report those to drugshortage@ehaweb. org.

Read more

EPICOVIDEHA survey

COVID-19 infections in patients with Hematological Malignancies - Results from EHA-IDWP registry
EPICOVIDEHA is an international open web-based registry for patients with haematological malignancies infected with SARS-CoV-2,
The survey has been approved by the Institutional Review Board and Ethics Committee of the…

Read more

Registration

Register here

Individual registrationHybrid registration includes:

In-person access to the scientific and educational sessions of the meeting
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8, 2025
Access to the Welcome Reception
Access to the Poster Session(s) and viewing of the physical…

Read more

Abstract submission

DEADLINE FOR SUBMISSION OF ABSTRACTS FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS: August 25th, 2024

CLICK HERE TO SUBMIT YOUR ABSTRACT!

Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will…

Read more

EHA Kick-off Grants

The call for applications will close on September 10, 2024, at 15:00 (CEST).   Apply now

The EHA Kick-off Grant is a one-year grant intended to support basic and translational early career researchers in hematology.

Read more